| For: | Zhu YZ, Qian XJ, Zhao P, Qi ZT. How hepatitis C virus invades hepatocytes: The mystery of viral entry. World J Gastroenterol 2014; 20(13): 3457-3467 [PMID: 24707128 DOI: 10.3748/wjg.v20.i13.3457] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i13/3457.htm |
| Number | Citing Articles |
| 1 |
I. T. Shawa, D. J. Felmlee, D. Hegazy, D. A. Sheridan, M. E. Cramp. Exploration of potential mechanisms of hepatitis C virus resistance in exposed uninfected intravenous drug users. Journal of Viral Hepatitis 2017; 24(12) doi: 10.1111/jvh.12720
|
| 2 |
Ioannis Tsomidis, Angeliki Tsakou, Argyro Voumvouraki, Elias Kouroumalis. Liver Macrophages in the Pathogenesis of Viral Hepatitis. Current Issues in Molecular Biology 2026; 48(7) doi: 10.3390/cimb48070687
|
| 3 |
J Alfredo Martínez, Marta Alonso-Bernáldez, Diego Martínez-Urbistondo, Juan A Vargas-Nuñez, Ana Ramírez de Molina, Alberto Dávalos, Omar Ramos-Lopez. Machine learning insights concerning inflammatory and liver-related risk comorbidities in non-communicable and viral diseases. World Journal of Gastroenterology 2022; 28(44): 6230-6248 doi: 10.3748/wjg.v28.i44.6230
|
| 4 |
J Ampuero, J A del Campo, L Rojas, R J García-Lozano, M Buti, R Solá, X Forns, R Moreno-Otero, R Andrade, M Diago, J Salmerón, L Rodrigo, J A Pons, J M Navarro, J L Calleja, J García-Samaniego, M García-Valdecasas, Á Rojas, R Millán, M F González-Escribano, M Romero-Gómez. Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infection. Genes & Immunity 2015; 16(5) doi: 10.1038/gene.2015.14
|
| 5 |
Chun-Chun Chang, Hao-Jen Hsu, Jui-Hung Yen, Shih-Yen Lo, Je-Wen Liou, Chiaho Shih. A Sequence in the loop domain of hepatitis C virus E2 protein identified in silico as crucial for the selective binding to human CD81. PLOS ONE 2017; 12(5) doi: 10.1371/journal.pone.0177383
|
| 6 |
Heather Ezelle, Krishnamurthy Malathi, Bret Hassel. The Roles of RNase-L in Antimicrobial Immunity and the Cytoskeleton-Associated Innate Response. International Journal of Molecular Sciences 2016; 17(1) doi: 10.3390/ijms17010074
|
| 7 |
Matteo Castelli, Nicola Clementi, Giuseppe A. Sautto, Jennifer Pfaff, Kristen M. Kahle, Trevor Barnes, Benjamin J. Doranz, Matteo Dal Peraro, Massimo Clementi, Roberto Burioni, Nicasio Mancini. HCV E2 core structures and mAbs: something is still missing. Drug Discovery Today 2014; 19(12) doi: 10.1016/j.drudis.2014.08.011
|
| 8 |
Tejabhiram Yadavalli, Ipsita Volety, Deepak Shukla. Aptamers in Virology—A Consolidated Review of the Most Recent Advancements in Diagnosis and Therapy. Pharmaceutics 2021; 13(10) doi: 10.3390/pharmaceutics13101646
|
| 9 |
Ravi Jhaveri, Samer S. El-Kamary. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. 2025; doi: 10.1016/B978-0-323-82763-8.00190-4
|
| 10 |
Dan Dong, Wei Xie, Min Liu. Alteration of cell junctions during viral infection. Thoracic Cancer 2020; 11(3) doi: 10.1111/1759-7714.13344
|
| 11 |
Laura-Sophie Beier, Jan Rossa, Stephen Woodhouse, Sophia Bergmann, Holger Kramer, Jonas Protze, Miriam Eichner, Anna Piontek, Sabine Vidal-y-Sy, Johanna Brandner, Gerd Krause, Nicole Zitzmann, Jörg Piontek. Use of Modified Clostridium perfringens Enterotoxin Fragments for Claudin Targeting in Liver and Skin Cells. International Journal of Molecular Sciences 2019; 20(19) doi: 10.3390/ijms20194774
|
| 12 |
|
| 13 |
Kun Zhao, Zhe Wang, Thilo Hackert, Claudia Pitzer, Margot Zöller. RETRACTED ARTICLE: Tspan8 and Tspan8/CD151 knockout mice unravel the contribution of tumor and host exosomes to tumor progression. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0961-6
|
| 14 |
|
| 15 |
Nejat Düzgüneş, Narcis Fernandez-Fuentes, Krystyna Konopka. Inhibition of Viral Membrane Fusion by Peptides and Approaches to Peptide Design. Pathogens 2021; 10(12) doi: 10.3390/pathogens10121599
|
| 16 |
Xi-Jing Qian, Xiao-Lian Zhang, Ping Zhao, Yong-Sheng Jin, Hai-Sheng Chen, Qing-Qiang Xu, Hao Ren, Shi-Ying Zhu, Hai-Lin Tang, Yong-Zhe Zhu, Zhong-Tian Qi. A Schisandra-Derived Compound Schizandronic Acid Inhibits Entry of Pan-HCV Genotypes into Human Hepatocytes. Scientific Reports 2016; 6(1) doi: 10.1038/srep27268
|
| 17 |
Rafid Jihad Albadr, Hayder Naji Sameer, Zainab H. Athab, Mohaned Adil, Ahmed Yaseen, Omer Qutaiba B. Allela. Recent Advances in mRNA-Based Vaccines Against Several Hepatitis Viruses. Biological Procedures Online 2025; 27(1) doi: 10.1186/s12575-025-00269-2
|
| 18 |
Chinmay Das, Chanakya Nath Kundu. Decoding the molecular complexity of viruses in human cancer: insights into host cell infection, oncogenesis, and therapeutic prospects. Critical Reviews in Microbiology 2025; 51(6) doi: 10.1080/1040841X.2025.2461045
|
| 19 |
Tutik Sri Wahyuni, Adita Ayu permatasari, Tri Widiandani, Achmad Fuad, Aty Widyawaruyanti, Chie Aoki-Utsubo, Hak Hotta. Antiviral Activities of Curcuma Genus against Hepatitis C Virus. Natural Product Communications 2018; 13(12) doi: 10.1177/1934578X1801301204
|
| 20 |
Sooram Banesh, Surajbhan Sevda. Bioreactor Design Concepts for Viral Vaccine Production. 2024; doi: 10.1016/B978-0-443-15378-5.00016-4
|
| 21 |
Yifan Wang, Quanxiang Yu, Shuru Lin, Wenqi Jiang, Zhengfei Qi, Lina Wang, Lian Wu, Rui Ma, Kexin Zhang, Shurong Chen, Jiayi Xie, Lingli Zheng, Min Zhou, Qingshan Bill Fu. Key Factors in the Multiple Mechanisms of Virus Entry. Health and Metabolism 2025; doi: 10.53941/hm.2025.100001
|
| 22 |
Catalina Mihai, Bogdan Mihai, Anca Trifan, Carol Stanciu, Liana Gheorghe, Mircea Diculescu, Manuela Curescu, Ciprian Brisc, Adrian Goldis, Simona Bataga, Larisa Sandulescu, Ion Rogoveanu, Andrada Seicean, Cristina Cijevschi Prelipcean. Metabolic Syndrome and Genotype 1 Virus C Compensated Liver Cirrhosis in the Era of Directly Acting Antiviral Therapy. Hepatitis Monthly 2017; 17(7) doi: 10.5812/hepatmon.58022
|
| 23 |
Nora A. Fierro, Evelyn Rivera-Toledo, Fernanda Ávila-Horta, Julio Y. Anaya-Covarrubias, Fela Mendlovic. Scavenger Receptors in the Pathogenesis of Viral Infections. Viral Immunology 2022; 35(3) doi: 10.1089/vim.2021.0167
|
| 24 |
Jens Mattern, Christian S. Roghi, Melanie Hurtz, Vera Knäuper, Dylan R. Edwards, Zaruhi Poghosyan. ADAM15 mediates upregulation of Claudin-1 expression in breast cancer cells. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-49021-3
|
| 25 |
Wen-Jun Shen, Salman Azhar, Fredric B. Kraemer. SR-B1: A Unique Multifunctional Receptor for Cholesterol Influx and Efflux. Annual Review of Physiology 2018; 80(1) doi: 10.1146/annurev-physiol-021317-121550
|
| 26 |
Manola Comar, Francesco De Seta, Nunzia Zanotta, Serena Del Bue, Pasquale Ferrante. Sexually Transmitted Infections. 2020; doi: 10.1007/978-3-030-02200-6_6
|
| 27 |
Qiu Pan, Yan Xie, Ying Zhang, Xinqi Guo, Jing Wang, Min Liu, Xiao-Lian Zhang. EGFR core fucosylation, induced by hepatitis C virus, promotes TRIM40-mediated-RIG-I ubiquitination and suppresses interferon-I antiviral defenses. Nature Communications 2024; 15(1) doi: 10.1038/s41467-024-44960-6
|
| 28 |
Clementina Sansone, Christophe Brunet, Douglas M. Noonan, Adriana Albini. Marine Algal Antioxidants as Potential Vectors for Controlling Viral Diseases. Antioxidants 2020; 9(5) doi: 10.3390/antiox9050392
|
| 29 |
Artur Yakimovich, Vardan Andriasyan, Robert Witte, I-Hsuan Wang, Vibhu Prasad, Maarit Suomalainen, Urs F. Greber, Oliver Schildgen. Plaque2.0—A High-Throughput Analysis Framework to Score Virus-Cell Transmission and Clonal Cell Expansion. PLOS ONE 2015; 10(9) doi: 10.1371/journal.pone.0138760
|
| 30 |
Ngan N. T. Nguyen, Yun-Sook Lim, Lap P. Nguyen, Si C. Tran, Trang T. D. Luong, Tram T. T. Nguyen, Hang T. Pham, Han N. Mai, Jae-Woong Choi, Sang-Seop Han, Soon B. Hwang. Hepatitis C Virus Modulates Solute carrier family 3 member 2 for Viral Propagation. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-33861-6
|
| 31 |
Otsubo Ryota, Teruhito Yasui. Monoclonal Antibody Therapeutics for Infectious Diseases: Beyond Normal Human Immunoglobulin. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4022365
|
| 32 |
Yunyun Wang, Jing Wang, Shanshan Wu, Haihong Zhu. The unexpected structures of hepatitis C virus envelope proteins. Experimental and Therapeutic Medicine 2017; 14(3) doi: 10.3892/etm.2017.4745
|
| 33 |
David Balgoma, Luis Gil-de-Gómez, Olimpio Montero. Lipidomics Issues on Human Positive ssRNA Virus Infection: An Update. Metabolites 2020; 10(9) doi: 10.3390/metabo10090356
|
| 34 |
Joost Boeckmans, Matthias Rombaut, Thomas Demuyser, Baptist Declerck, Denis Piérard, Vera Rogiers, Joery De Kock, Luc Waumans, Koen Magerman, Reinoud Cartuyvels, Jean-Luc Rummens, Robim M. Rodrigues, Tamara Vanhaecke. Infections at the nexus of metabolic-associated fatty liver disease. Archives of Toxicology 2021; 95(7) doi: 10.1007/s00204-021-03069-1
|
| 35 |
Ryan P McNamara, Dirk P Dittmer. Extracellular vesicles in virus infection and pathogenesis. Current Opinion in Virology 2020; 44 doi: 10.1016/j.coviro.2020.07.014
|
| 36 |
Trang H. Au, Christopher J. Destache, Renuga Vivekanandan. Hepatitis C therapy: Looking toward interferon-sparing regimens. Journal of the American Pharmacists Association 2015; 55(2) doi: 10.1331/JAPhA.2015.15508
|
| 37 |
Xiaoyan Chu, Bhagwat Prasad, Sibylle Neuhoff, Kenta Yoshida, James Steven Leeder, Dwaipayan Mukherjee, Kunal Taskar, Manthena V. S. Varma, Xinyuan Zhang, Xinning Yang, Aleksandra Galetin. Clinical Implications of Altered Drug Transporter Abundance/Function and PBPK Modeling in Specific Populations: An ITC Perspective. Clinical Pharmacology & Therapeutics 2022; 112(3) doi: 10.1002/cpt.2643
|
| 38 |
Charline Herrscher, Philippe Roingeard, Emmanuelle Blanchard. Hepatitis B Virus Entry into Cells. Cells 2020; 9(6) doi: 10.3390/cells9061486
|
| 39 |
Hui-Chun Li, Shih-Yen Lo. Hepatitis C virus: Virology, diagnosis and treatment. World Journal of Hepatology 2015; 7(10): 1377-1389 doi: 10.4254/wjh.v7.i10.1377
|
| 40 |
Justin O. Ortiz, Jeffrey B. Brown, Ajay K. Varadhan, Charles Preuss. Infectious Diseases Drug Delivery Systems. 2023; doi: 10.1007/978-3-031-20521-7_3
|
| 41 |
Evgeny Knyazev, Stepan Nersisyan, Alexander Tonevitsky. Endocytosis and Transcytosis of SARS-CoV-2 Across the Intestinal Epithelium and Other Tissue Barriers. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.636966
|
| 42 |
ROBERT S. EGERMAN. New Antiviral Agents for Treatment of Hepatitis C. Clinical Obstetrics & Gynecology 2019; 62(4) doi: 10.1097/GRF.0000000000000457
|
| 43 |
Matteo Castelli, Nicola Clementi, Jennifer Pfaff, Giuseppe A. Sautto, Roberta A. Diotti, Roberto Burioni, Benjamin J. Doranz, Matteo Dal Peraro, Massimo Clementi, Nicasio Mancini. A Biologically-validated HCV E1E2 Heterodimer Structural Model. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-00320-7
|
| 44 |
Yoshio Aizawa, Nobuyoshi Seki, Tomohisa Nagano, Hiroshi Abe. Chronic hepatitis C virus infection and lipoprotein metabolism. World Journal of Gastroenterology 2015; 21(36): 10299-10313 doi: 10.3748/wjg.v21.i36.10299
|
| 45 |
Shivam Chowdhary, Rahul Deka, Kingshuk Panda, Rohit Kumar, Abhishikt David Solomon, Jimli Das, Supriya Kanoujiya, Ashish Kumar Gupta, Somya Sinha, Janne Ruokolainen, Kavindra Kumar Kesari, Piyush Kumar Gupta. Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities. Molecular Pharmaceutics 2023; 20(8) doi: 10.1021/acs.molpharmaceut.2c01080
|
| 46 |
Wing Sum Shin, Fuda Xie, Bonan Chen, Jun Yu, Kwok Wai Lo, Gary M. K. Tse, Ka Fai To, Wei Kang. Exploring the Microbiome in Gastric Cancer: Assessing Potential Implications and Contextualizing Microorganisms beyond H. pylori and Epstein-Barr Virus. Cancers 2023; 15(20) doi: 10.3390/cancers15204993
|
| 47 |
Ryota Otsubo, Teruhito Yasui. Monoclonal antibody therapeutics for infectious diseases: Beyond normal human immunoglobulin. Pharmacology & Therapeutics 2022; 240 doi: 10.1016/j.pharmthera.2022.108233
|
| 48 |
Natasha M. Bourgeois, Ling Wei, Alexis Kaushansky, John D. Aitchison. Exploiting host kinases to combat dengue virus infection and disease. Antiviral Research 2025; 241 doi: 10.1016/j.antiviral.2025.106172
|
| 49 |
Mohammad Irshad, Priyanka Gupta, Khushboo Irshad. Immunopathogenesis of Liver Injury During Hepatitis C Virus Infection. Viral Immunology 2019; 32(3) doi: 10.1089/vim.2018.0124
|
| 50 |
Saurav Sarkar, Prajna Gupta, Gouranga Nandi, Ranabir Sahu, Paramita Paul, Tarun Kumar Dua, Sreejan Manna. The Role of Nutraceuticals in Degenerative Diseases (Part 2). 2026; doi: 10.2174/9798898813369126010008
|
| 51 |
Ee Hong Tam, Yu Peng, Megan Xin Yan Cheah, Chuan Yan, Tianshu Xiao. Neutralizing antibodies to block viral entry and for identification of entry inhibitors. Antiviral Research 2024; 224 doi: 10.1016/j.antiviral.2024.105834
|
| 52 |
Luís Jesuino de Oliveira Andrade, Alexandre Pithon Lins, Lorena Pithon Lins, Raymundo Paraná, Augusto Cesar Ferreira Lins. Hepatite C e tireoide. 2021; doi: 10.7476/9786586213737.0003
|
| 53 |
Yu-De Chu, Mi-Chi Chen, Chau-Ting Yeh, Ming-Wei Lai. Hijacking host extracellular vesicle machinery by hepatotropic viruses: current understandings and future prospects. Journal of Biomedical Science 2024; 31(1) doi: 10.1186/s12929-024-01063-0
|
| 54 |
Xiaofeng Dai, Xuanhao Zhang, Kostya Ostrikov, Levon Abrahamyan. Host receptors: the key to establishing cells with broad viral tropism for vaccine production. Critical Reviews in Microbiology 2020; 46(2) doi: 10.1080/1040841X.2020.1735992
|
| 55 |
Janelle Johnson, Holly Freedman, Michael Logan, Jason Alexander Ji-Xhin Wong, Darren Hockman, Chao Chen, Jianqi He, Michael R. Beard, Nicholas S. Eyre, Thomas F. Baumert, D. Lorne Tyrrell, John L. M. Law, Michael Houghton, J.-H. James Ou. A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1. Journal of Virology 2019; 93(22) doi: 10.1128/JVI.00810-19
|